Kaplan-Meier curves for patients with advanced hepatocellular carcinoma and main portal vein tumor thrombosis for the T+S and S groups. (A): The median OS for the T+S group (n = 43) was 7.0 months, and 6.0 months for the S group (n = 44) (p = .924). (B): The median TTP for the T+S group (n = 43) and the S group was 3.0 months for both groups (p = .544).

Abbreviations: OS, overall survival; S, sorafenib monotherapy; T+S, combination sorafenib plus transarterial chemoembolization; TTP, time to progression.